In general, hepatic encephalopathy (HE) is defined as a brain dysfunction caused by liver
insufficiency and/or portal-systemic blood shunting. This article relates to the so-called type …

Aliment Pharmacol Ther 2011; 33: 739–747 Summary Background The clinical classification
of hepatic encephalopathy is largely subjective, which has led to difficulties in designing …

Summary The EASL Clinical Practice Guidelines (CPGs) on the management of hepatic
encephalopathy (HE) present evidence-based answers to a set of relevant questions (where …

Abstract Background and Aims Large spontaneous portosystemic shunt (SPSS) is
associated with increased risk of HE in patients undergoing transjugular intrahepatic …

Background & Aims Spontaneous portosystemic shunts (SPSS) have been associated with
hepatic encephalopathy (HE). Little is known about their prevalence among patients with …

Refractory hepatic encephalopathy (HE) remains a major cause of morbidity in cirrhosis
patients. Large spontaneous portosystemic shunts (SPSSs) have been previously …

Background & Aims Spontaneous portosystemic shunts (SPSS) frequently develop in liver
cirrhosis. Recent data suggested that the presence of a single large SPSS is associated with …

Abstract Background and Aims Although NASH can lead to severe clinical consequences,
including cirrhosis and hepatocellular carcinoma, no effective treatment is currently …

Aliment Pharmacol Ther 31, 537–547 Summary Background Hepatic encephalopathy, both
overt and minimal, forms a continuum of cognitive change in cirrhosis. Strategies to …

Hepatic encephalopathy is a spectrum of reversible neuropsychiatric abnormalities, seen in
patients with liver dysfunction and/or portosystemic shunting. One of the most debilitating …